How to buy MEDNAX stock

MEDNAX, Inc is a medical care facilities business based in the US. MEDNAX shares (MD) are listed on the NYSE and all prices are listed in US Dollars. MEDNAX employs 9,480 staff and has a trailing 12-month revenue of around USD$1.7 billion.

How to buy shares in MEDNAX

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for MEDNAX. Find the stock by name or ticker symbol: MD. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until MEDNAX reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of MEDNAX, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of MEDNAX. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

MEDNAX share price

Use our graph to track the performance of MD stocks over time.

MEDNAX shares at a glance

• Key figures

Information last updated 2021-02-23.

52-week range	USD$7.37 - USD$28.92
50-day moving average	USD$25.1359
200-day moving average	USD$20.2579
Wall St. target price	USD$20.35
PE ratio	9.15
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-1.441

Buy MEDNAX shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy MEDNAX stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of MEDNAX, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

MEDNAX financials

Revenue TTM	USD$1.7 billion
Operating margin TTM	9.92%
Gross profit TTM	USD$449.3 million
Return on assets TTM	2.87%
Return on equity TTM	-0.85%
Profit margin	-45.94%
Book value	$8.858
Market capitalisation	USD$2 billion

TTM: trailing 12 months

Shorting MEDNAX shares

There are currently 11.9 million MEDNAX shares held short by investors – that's known as MEDNAX's "short interest". This figure is 3.6% down from 12.3 million last month.

There are a few different ways that this level of interest in shorting MEDNAX shares can be evaluated.

MEDNAX's "short interest ratio" (SIR)

MEDNAX's "short interest ratio" (SIR) is the quantity of MEDNAX shares currently shorted divided by the average quantity of MEDNAX shares traded daily (recently around 1.0 million). MEDNAX's SIR currently stands at 11.55. In other words for every 100,000 MEDNAX shares traded daily on the market, roughly 11550 shares are currently held short.

However MEDNAX's short interest can also be evaluated against the total number of MEDNAX shares, or, against the total number of tradable MEDNAX shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case MEDNAX's short interest could be expressed as 0.14% of the outstanding shares (for every 100,000 MEDNAX shares in existence, roughly 140 shares are currently held short) or 0.1632% of the tradable shares (for every 100,000 tradable MEDNAX shares, roughly 163 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against MEDNAX.

Find out more about how you can short MEDNAX stock.

MEDNAX's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like MEDNAX.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

MEDNAX's total ESG risk score

Total ESG risk: 19.73

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and MEDNAX's overall score of 19.73 (as at 01/01/2019) is pretty good – landing it in it in the 22nd percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like MEDNAX is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

MEDNAX's environmental score

Environmental score: 1.84/100

MEDNAX's environmental score of 1.84 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that MEDNAX is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

MEDNAX's social score

Social score: 8.57/100

MEDNAX's social score of 8.57 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that MEDNAX is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

MEDNAX's governance score

Governance score: 5.5/100

MEDNAX's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that MEDNAX is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

MEDNAX's controversy score

Controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. MEDNAX scored a 1 out of 5 for controversy – the highest score possible, reflecting that MEDNAX has managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

MEDNAX, Inc was last rated for ESG on: 2019-01-01.

Total ESG score	19.73
Total ESG percentile	21.62
Environmental score	1.84
Environmental score percentile	1
Social score	8.57
Social score percentile	1
Governance score	5.5
Governance score percentile	1
Level of controversy	1

Have MEDNAX's shares ever split?

MEDNAX's shares were split on a 2:1 basis on 20 December 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your MEDNAX shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for MEDNAX shares which in turn could have impacted MEDNAX's share price.

MEDNAX share price volatility

Over the last 12 months, MEDNAX's shares have ranged in value from as little as $7.37 up to $28.92. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MEDNAX's is 2.1163. This would suggest that MEDNAX's shares are significantly more volatile than the average for this exchange and represent a higher risk.

MEDNAX overview

MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and their unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patients with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, pediatric ophthalmology, other newborn pediatric care, and newborn hearing screening program, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. Additionally, it offers consulting services to healthcare facilities and physicians. As of March 12, 2020, the company operated a network of approximately 4,325 physicians. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida.

Frequently asked questions

• What percentage of MEDNAX is owned by insiders or institutions?

  Currently 3.389% of MEDNAX shares are held by insiders and 101.125% by institutions.

• How many people work for MEDNAX?

  Latest data suggests 9,480 work at MEDNAX.

• When does the fiscal year end for MEDNAX?

  MEDNAX's fiscal year ends in December.

• Where is MEDNAX based?

  MEDNAX's address is: 1301 Concord Terrace, Sunrise, FL, United States, 33323

• What is MEDNAX's ISIN number?

  MEDNAX's international securities identification number is: US58502B1061

• What is MEDNAX's CUSIP number?

  MEDNAX's Committee on Uniform Securities Identification Procedures number is: 58502B106